Abstract
Breast malignancies are almost exclusively epithelial cancers. Epithelial cells that have undergone malignant transformation arise from ductal or lobular elements within the breast parenchyma. However, no breast cancer can grow beyond the microscopic level simply as a proliferation of malignant epithelium. Clinically significant breast tumors are a complex and heterogeneous mix of epithelium, stromal cells, matrix proteins, and vascular elements. The growth and dissemination of a breast cancer requires complex but poorly understood interactions between these various tumor elements. To grow beyond the microscopic level, a tumor must acquire a blood supply. To acquire invasive or metastatic potential, a tumor must be able to manipulate and degrade surrounding basement membrane and intercellular matrix to escape into lymphatic or vascular channels. These same properties may be necessary for a metastatic tumor focus to develop at a distance from the primary tumor.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Sakakura, T. (1991) New aspects of stroma-parenchyma relations in mammary gland differentiation. Int. Rev. Cytol. 125:165–202.
Sakakura, T., Nishizuka, Y., Dawe, C.J. (1979) Capacity of mammary fat pads of adult C3H/HeMs mice to interact morphogenetically with fetal mammary epithelium. J. Natl. Cancer Inst. 63:733–736.
Sakakura, T., Sakagami, Y., Nishizuka, Y. (1979) Persistence of responsiveness to adult mammary gland to induction by embryonic mesenchyme. Dev. Biol. 72:201–210.
Durnberger, H., Heuberger, B., Schwartz, P., Wasner, G., Kratochwil, K. (1978) Mesenchyme-mediated effect of testosterone on embryonic mammary epithelium. Cancer Res. 38:4066–4070.
Haslam, S.Z. (1989) The ontogeny of mouse mammary gland responsiveness to ovarian steroid hormones. Endocrinology 125:2766–2772.
Narbzitz, R., Stumpf, W.E., Sar, M. (1980) Estrogen receptors in mammary gland primordia of fetal mouse. Anat. Embryol. 158:161–168.
Reichmann, E., Ball, R., Groner, B., Friis, R.R. (1989) New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J. Cell Biol. 108:1127–1138.
Wicha, M.S., Lowrie, G., Kohn, E., Bagavandoss, P., Mahn, T. (1982) Extracellular matrix promotes mammary epithelial growth and differentiation in vitro. Proc. Natl. Acad. Sci. U.S.A. 79:3213–3217.
Li, M.L., Aggeler, J., Farson, D.A., Hatier, C., Hassell, J., Bissell, M.J. (1987) Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 84:136–140.
Bissell, M.J., Ram, T.J. (1989) Regulation of functional cytodifferentiation and histogenesis in mammary epithelial cells: Role of the extracellular matrix. Environ. Health Perspect. 80:61–70.
Streuli, C.H., Bissell, M.J. (1990) Expression of extracellular matrix components is regulated by substratum. J. Cell Biol. 110:1405–1415.
Chiquet-Ehrismann, R., Kalla, P., Pearson, C.A., Beck, K., Chiquet, M. (1988) Tenascin interferes with fibronectin action. Cell 53:383–390.
Knabbe, C., Lippman, M.E., Wakefield, L.M., Flanders, K.C., Kasid, A., Derynck, R., Dickson, R.B. (1987) Evidence that transforming growth factor beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417–428.
Chiquet-Ehrismann, R., Kalla, P., Pearson, C.A. (1989) Participation of tenascin and transforming growth factor-B in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts. Cancer Res. 49:4322–4325.
Gherardi, E., Gray, J., Stoker, M., Perryman, M., Furlong, R. (1989) Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci U.S.A. 86:5844–5848.
Laiho, M., Keski-Oja, J. (1989) Growth factors in the regulation of pericellular proteolysis: A review. Cancer Res. 49:2533–2553.
Khokha, R., Denhardt, D.T. (1989) Matrix metalloproteinases and tissue inhibitor of metalloproteinases: A review of their role in tumorigenesis and tissue invasion. Invasion Metastasis 9:391–405.
Laug, W.E., Jones, P.A., Benedict, W.F. (1975) Relationship between fibrinolysis of cultured cells and malignancy. J. Natl. Cancer Inst. 54:173–179.
Butler, W.B., Kirkland, W.L., Jorgenson, T.L. (1979) Induction of plasminogen activator by estrogen in a human breast cancer cell line MCF-7. BBRC. 90:1328–1334.
Ryan, T.J., Seeger, J.I., Kumar, A., Dickerman, H.W. (1984) Estradiol preferentially enhances extracellular tissue plasminogen activators of MCF-7 breast cancer cells. J. Biol. Chem. 259:14324–14327.
Mira-y-Lopz, R., Ossowski, L. (1987) Hormonal modulation of plasminogen activator: An approach to the prediction of human breast tumor responsiveness. Cancer Res. 47:3558–3564.
Duffy, M.J., O’Grady, P., Simon, J., Rose, M., Lijnen, H.R. (1986) Tissue-type plasminogen activator in breast cancer: Relationship with estradiol and progesterone receptors. J. Natl. Cancer Inst. 77:621–623.
Duffy, M.J., Reilly, D., O’Sullivan, C., O’Higgans, N., Fennelly, J.J., Andreasen, P. (1990) Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res. 50:6827–6829.
Shafie, S.M., Liotta, L.A. (1980) Formation of metastasis by human breast carcinoma cells in nude mice. Cancer Lett. 11:81–87.
Barsky, S.H., Togo, S., Spiridione, G., Liotta, L. (1983) Type IV collagenase immunoreactivity in invasive breast carcinoma. Lancet 1:296–297.
Ogilvie, D.J., Hailey, J.A., Juacaba, S.F., Lee, E., Tarin, D. (1985) Collagenase secretion by human breast neoplasms: A clinicopathologic investigation. J. Natl. Cancer Inst. 74: 19–27.
Montagudo, C., Merino, M.J., San-Juan, J., Liotta, L., Stetler-Stevenson, W.G. (1990) Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am. J. Pathol. 136:585–592.
D’Errico, A., Garbisa, S., Liotta, L.A., Castronovo, V., Stetler-Stevenson, W.G., Grigioni, W.F. (1991) Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod. Pathol. 4:239–246.
Daidon, M.G., Silvestrini, R., D’Errico, A., Di Fronzo, G., Benini, E., Mancini, A.M., Garbisa, S., Liotta, L.A., Grigioni, W.F. (1991) Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int. J. Cancer 48:529–532.
Basset, P., Bellocq, J.P., Wolf, C., Stoll, I., Hutin, P., Limacher, J.M., Podhajcer, O.L., Chenard, M.P., Rio, M.C., Chambon, P. (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699–704.
Rinnov-Jessen, L., van Deurs, B., Celis, J.E., Peterson, O.W. (1990) Smooth muscle differentiation in cultured human breast gland stromal cells. Lab Invest. 63:532–543.
Ahmed, A. (1990) The myofibroblast in breast disease. Pathol. Annu. 25:237–286.
Sappino, A.P., Skalli, O., Jackson, B., Schurch, W., Gabbiani, G. (1988) Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 41:707–712.
Pfeffer, L., Lipkin, M., Stutman, O., Kopelovich, L. (1976) Growth abnormalities of cultured human skin fibroblasts derived from individuals with hereditary adenomatosis of the colon and rectum. J. Cell Physiol. 80:29–38.
Azzarone, B., Mareel, M., Billard, C., Scemama, P., Chaponnier, C., Maciera-Coelho A. (1984) Abnormal properties of skin fibroblasts from patients with breast cancer. Int. J. Cancer 33:759–764.
Azzarone, B., Maciera-Coelho, A. (1987) Further characterization of the defects of skin fibroblasts from cancer patients. J. Cell Sci. 87:155–162.
Schor, S.L., Schor, A.M., Durning, P., Rushton, G. (1985) Skin fibroblasts obtained from cancer patients display foetal-like migratory behaviour on collagen gels. J. Cell Sci. 73:235–244.
Schor, S.L., Schor, A.M., Howell, A., Crowther, D. (1987) Hypothesis: Persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease. Exp. Cell Biol. 55:11–17.
Schor, S.L., Schor, A.M., Grey, A.M., Rushton, G. (1988) Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. J. Cell Sci. 90:391–399.
Grey, A.M., Schor, A.M., Rushton, G., Ellis, I., Schor, S.L. (1989) Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 86:2438–2442.
Picardo, M., Schor, S.L., Grey, A.M., Howell, A., Laidlaw, I., Redford, J., Schor, A.M. (1991) Migration stimulating activity in serum of breast cancer patients. Lancet 337:130–133.
Adams, E.F., Newton, C.J., Braunsberg, H., Shaikh, N., Ghilchik, M., James, V.H.T. (1988) Effects of human breast fibroblasts on growth and 17β-estradiol dehydrogenase activity of MCF-7 cells in culture. Breast Cancer Res. Treat. 11:165–172.
Camps, J.L., Chang, S.-M., Hsu, T.C., Freeman, M.R., Hong, S.-J., Zhau, H.E., von Eschenbach, A.C., Chung, L.W.K. (1990) Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl. Acad. Sci. U.S.A. 87:75–79.
Horgan, K., Jones, D.L., Mansel, R.E. (1987) Mitogenicity of human fibroblasts in vivo for human breast cancer cells. Br. J. Surg. 74:227–229.
Horgan, K., Jones, D.L., Mansel, R.E. (1988) Stromal stimulation of human breast cancer growth and development. Progr. Cancer Rese. Ther. 35 (Hormones Cancer 3):179–182.
Haslam, S.Z., Levely, M.L. (1985) Estradiol responsiveness of normal mouse epithelial cells in primary culture: Association of mammary fibroblasts with estradiol regulation of progesterone receptors. Endocrinology 116:1835–1844.
Haslam, S.Z. (1986) Mammary fibroblast influence on normal mouse mammary epithelial cell responses to estrogen in vitro. Cancer Res. 46:310–316.
Adams, E.F., Newton, C.J., Tait, G.H., Braunsberg, H., Reed, M.J., James, V.H.T. (1988) Paracrine influence of human breast stromal fibroblasts on breast epithelial cells: Secretion of a polypeptide which stimulates reductive 17B-oestradiol dehydrogenase activity. Int. J. Cancer 42:119–122.
Valverius, E.M., Ciadiello, F., Heldin, N.-E., Blondel, B., Merlo, G., Smith, G., Stampfer, M.R., Lippman, M.E., Dickson, R.B., Salomon, D.S. (1990) Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T. J. Cell Physiol. 145:207–216.
Peres, R., Betsholtz, C., Westermark, B., Heldin, C. (1987) Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res. 47:3425–3429.
Gospodarowicz, D., Ferrara, N., Schweigerer, L., Neufeld, G. (1987) Structural characterization and biological functions of fibroblast growth factor. Endocrine Rev. 8:95–114.
Folkman, J., Watson, K., Ingber, D., Hanahan, D. (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58–61.
Furlanetto, R.W., DiCarlo, J.N. (1884) Somatomedin-C receptors and growth effects in human breast cells maintained in long term tissue culture. Cancer Res. 44:2122–2128.
Myal, Y., Shiu, R.P.C., Bhaumick, B. (1984) Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res. 44:5486–5490.
Yee, D., Cullen, K.J., Paik, S., Perdue, J.F., Hampton, B., Schwartz, A., Lippman, M.E., Rosen, N. (1988) Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res. 48:6691–6696.
Karey, K.P., Sirbasku, D.A. (1988) Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β estradiol. Cancer Res. 48:4083–4092.
Yee, D., Paik, S., Lebovic, G., Marcus, R., Favoni, R., Cullen, K., Lippman, M., Rosen, N. (1989) Analysis of IGF-I gene expression in malignancy — evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 3:509–517.
Hoopener, J.W.M., Mosselman, S., Roholl, P.J.M. (1988) Expression of insulin-like growth factor I and II genes in human smooth muscle tumours. EMBO J. 7:1379–1385.
Tricoli, J.V., Rall, L.B., Karakousis, C.P. (1986) Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 46:6169–6173.
DeLeon, D.D., Bakker, B., Wilson, D.M., Rosenfeld, R.G. (1988) Demonstration of insulin-like growth factor (IGF-I and-II) receptors and binding protein in human breast cancer cell lines. Biochem. Biophys. Res. Comm. 152:398–405.
Pollak, M.N., Perdue, J.F., Margolese, R.G., Baer, K., Richard, M. (1987) Presence of somatomedin receptors on human breast and colon carcinomas. Cancer Lett. 38:223–230.
Peyrat, J.-P., Bonneterre, J., Beuscart, R., Dijane, J., Demaille, A. (1988) Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res. 48:6429–6433.
Peyrat, J.P., Bonneterre, J., Laurent, J.C. (1988) Presence and characterization of insulinlike growth factor 1 receptors in human benign breast disease. Eur. J. Cancer Clin. Oncol. 24:1425–1431.
Cullen, K.J., Yee, D., Sly, W.S., Perdue, J., Hampton, B., Lippman, M.E., Rosen, N. (1990) Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 50:48–53.
Osborne, C.K., Coronado, E.B., Kitten, L.J., Arteaga, C.I., Fuqua, S.A., Ramasharma, K., Marshall, M., Li, C.H. (1989) Insulin-like growth factor-II (IGF-II): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol. 3:1701–1709.
Rohlik, Q.T., Adams, B., Kull, F.C., Jacobs, S. (1987) An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. BBRC 149:276–281.
Artega, C.L., Kitten, L., Coronado, E., Jacobs, S., Kull, F.C., Allred, D.C., Osborne, C.K. (1989) Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J. Clin. Invest. 84:1418–1423.
Cullen, K.J., Smith, H.S., Hill, S., Rosen, N., Lippman, M.E. (1991) Growth factor mRNA expression by human breast fibroblasts from benign and malignant tissues. Cancer Res., in press.
Tucker, R.F., Shipley, G.D., Moses, H.L., Holley, R.W. (1984) Growth inhibitor from BSC-I cells closely related to platelet type beta transforming growth factor. Science. 226:705–707.
Roberts, A.B., Anzano, M.A., Wakefield, L.M., Roche, N.S., Stern, D.F., Sporn, M.B. (1985) Type one beta transforming growth factor: A bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. U.S.A. 82:119–123.
Bronzert, D.A., Pantazis, P., Antoniades, H.N., Kasid, A., Davidson, N., Dickson, R.B., Lippman, M.E. (1987) Synthesis and secretion of platelet derived growth factor by human breast cancer cell lines. Proc. Natl. Acad. Sci. U.S.A. 84:5763–5767.
Nonomura, N., Lu, J., Tanaka, A., Yamanishi, H., Sato, B., Sonoda, T., Matsumoto, K. (1990) Interaction of androgen induced autocrine heparine-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells. Cancer Res. 50:2316–2321.
Gemmons, D.R. (1984) Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts. J. Clin. Endocrinol. Metab. 58:850–856.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cullen, K.J., Lippman, M.E. (1991). Stromal-epithelial interactions in breast cancer. In: Dickson, R.B., Lippman, M.E. (eds) Genes, Oncogenes, and Hormones. Cancer Treatment and Research, vol 61. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3500-3_20
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3500-3_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6552-5
Online ISBN: 978-1-4615-3500-3
eBook Packages: Springer Book Archive